|
|
Consultants at Trinity Partners are active in the publication of research in a number of different areas. Many on the Trinity Team are seen as authoritative figures across various markets and are at the forefront of the changing healthcare environment. Below is a selection of recent publications released by members of Trinity’s staff.
1. Troy Norris, Amit Mehta, Eric David, Navjot Singh, Tony Tramontin. New Frontiers in Pharma R&D Investment. INVIVO. 2009 Nov. link to abstract
2. Phyllis J. Filker, D.M.D.; Erin Joy Muckey, B.A.; Steven M. Kelner, D.M.D., M.S.; Jodi Kodish-Stav, D.D.S., F.A.G.D. Taking a quality assurance program from paper to electronic health records: one dental school's experience. J Dent Educ. 2009 Sep; 73(9): 1095-101. link to abstract
3. Clark MJ and Million RP. Allergic rhinitis: market evolution. Nature Rev Drug Disc. 2009 Apr 8(4): 271-2. link to abstract
4. McKee AC, Cantu RC, Nowinski CJ, Hedley-Whyte ET, Gavett BE, Budson AE, Santini VE, Lee H-Y, Kubilus CA, Stern RA. Chronic Traumatic Encephalopathy in Athletes: Progressive Tauopathy following Repetitive Head Injury. J Neuropath Exp Neurol, 2009; 68(7): 709-735. link to abstract
5. Million RP. Therapeutic area crossroads: anti-angiogenesis. Nature Rev Drug Disc. 2008 Feb; 7(2): 115-6. link to abstract
6. Mondoux, Michelle A., Scaife, Jillian G., and Virginia A. Zakian. Differential nuclear localization does not determine the silencing status of Saccharomyces cerevisiae telomeres. Genetics. 2007 Dec; 177(4):2019-2029. link to abstract
7. Herrick TM and Million RP. Tapping the Potential of Fixed-dose Combinations. Nature Rev Drug Disc. 2007 Jul; 6(7): 513-4. link to abstract
8. Kirchner JE, Zubritsky C, Cody M, Coakley E, Chen H, Ware JH, Oslin DW, Sanchez HA, Durai UN, Miles KM, Llorente MD, Costantino G, Levkoff S. J Gen Intern Med. Alcohol consumption among older adults in primary care. 2007 Jan; 22(1):92-7. link to abstract
9. Million RP. Impact of genetic diagnostics on drug development strategy. Nature Rev Drug Disc. 2006 Jun; 5(6):459-62. link to abstract
10. Chen, H., Deshpande, A.D. et al. An Epidemiological Investigation of Off-label Anticonvulsant Use in the GA Medicaid Population. Pharmacoepidemiology and Drug Safety. 2005 Sep;14(9):629-38. link to abstract
11. Perri III, M, Menon, A.M., Deshpande, A.D. et al. Adverse Health Outcomes Associated with Inappropriate Drug Use in the GA Medicaid Nursing Home. Annals of Pharmacotherapy. 2005 Mar; 39(3):405-11. link to abstract
12. Fitzhenry D. and Sandberg L. Female Sexual Dysfunction. Nature Rev Drug Disc. 2005 Feb; 4: 99-100. link to abstract
13. Deshpande, A.D. et al. DTC Advertising & its Utility in Health Care Decision-making: A Consumer Perspective. Journal of Health Communication, 9(5), 2004 Nov-Dec; 9(6):499-513. link to abstract
14. Deshpande, A.D. et al. A survey of professional pharmacy student involvement in wellness programs in the US. American Journal of Pharmaceutical Education, September 2004. link to abstract
15. Gallo JJ, Zubritsky C, Maxwell J, Nazar M, Bogner HR, Quijano LM, Syropoulos HJ, Cheal KL, Chen H, Sanchez H, Dodson J, Levkoff SE; PRISM-E Investigators. Primary care clinicians evaluate integrated and referral models of behavioral health care for older adults: results from a multisite effectiveness trial (PRISM-e). Ann Fam Med. 2004 Jul-Aug;2(4):305-9. link to abstract
16. Million RP, Harakawa N, Roumiantsev S, Varticovski L, Van Etten RA. A direct binding site for Grb2 contributes to transformation and leukemogenesis by the Tel-Abl (ETV6-Abl) tyrosine kinase. Mol Cell Biol. 2004 Jun;24(11):4685-95. link to abstract
17. Menon, A.M., Deshpande, A.D., Zinkhan, G.M., Perri, M. III. A model assessing the effectiveness of direct-to-consumer advertising: integration of concepts and measures from marketing and healthcare, International Journal of Advertising, 2004; Vol. 23 No.1, pp.91-117. link to abstract
18. Deshpande, A.D. et al. The Utility of Direct-to-Consumer Advertising for Health Care Decision-making: A Consumer Perspective. Advances in Health Care Research, CD version. January 2004. link to abstract
19. Menon, A.M., Deshpande, A.D. et al. Consumers’ Attention to the Brief Summary in Print DTC Advertisements. Journal of Public Policy and Marketing, 22(2), p. 181-191. Fall 2003. link to abstract
20. Levkoff S, Sanchez H. Lessons learned about minority recruitment and retention from the Centers on Minority Aging and Health Promotion. Gerontologist. 2003 Feb;43(1):18-26. link to abstract
21. Million RP, Aster J, Gilliland DG and Van Etten RA. The Tel-Abl (ETV6-Abl) tyrosine kinase, product of complex (9;12) translocations in human leukemia, induces distinct myeloproliferative disease in mice. Blood. 2002 Jun 15; 99(12):4568-77. link to abstract
22. Menon, A.M., Deshpande, A.D. et al. (2002) Trust in On-line Prescription Drug Information among Internet Users: The Impact on Information Search Behavior after Exposure to DTC Advertising. Health Marketing Quarterly, 2002; 20(1), p. 17-35. link to abstract
23. Million RP and Van Etten RA. The Grb2 binding site is required for the induction of chronic myeloid leukemia-like disease in mice by the Bcr/Abl tyrosine kinase. Blood. 2000 Jul 15;96(2):664-70. link to abstract
24. Li S, Ilaria RL Jr., Million RP, Daley GQ and Van Etten RA. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J Exp Med. 1999 May 3; 189(9):1399-412. link to abstract
25. American Geriatric Society Abstract
Epoetin Alfa (EPO) Utilization Trends in Medicare Patients Age > 65 years with Chronic Kidney Disease (CKD) not on Dialysis
Fotios Kokkotos, Robert A. Bailey, Matthew Kerr, Sherlynn Shen, Mekre Senbetta, R. Scott McKenzie
26. International Society of Pharmacoeconomics and Outcomes Research Abstract
RECENT ERYTHROPOIESIS STIMULATING AGENT (ESA) UTILIZATION AND COSTS IN MEDICARE PATIENTS AGE>=65 YEARS WITH CHRONIC KIDNEY DISEASE (CKD)
Fotios Kokkotos, Robert A. Bailey, Matthew Kerr, Sherlynn Shen, Mekre Senbetta, R. Scott McKenzie
27. National Kidney Foundation Abstract
RECENT ERYTHROPOIESIS STIMULATING AGENT (ESA) UTILIZATION AND COSTS IN MEDICARE PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD)
Fotios Kokkotos, Robert A. Bailey, Matthew Kerr, Sherlynn Shen, Mekre Senbetta, R. Scott McKenzie
|
|
